To use our website in an optimal way, please activate JavaScript in your Browser.

J Musculoskelet Neuronal Interact., 2011; 11(1): 34-45, PMID: 21364273

Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass

Year: 2011

Felsenberg D, Bock O, Börst H, Armbrecht G, Beller G, Degner C, Stephan-Oelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M
Center of Muscle and Bone Research, Charité - University Medicine Berlin, Campus Benjamin Franklin, Free University and Humboldt University Berlin, Berlin, Germany.


Objectives: Assessment of additive impact of alfacalcidol 1

GID: 2587; Last update: 05.03.2011
More information: Original Article